Business Description
Vaxxa AB
SIC : 5331
ISIN : SE0021629953
Share Class Description:
XSAT:VAXXA: Ordinary SharesTotal Employee Number:
8Compare
Compare
Traded in other countries / regions
VAXXA.Sweden7WA0.Germany IPO Date
2017-10-26Description
Vaxxa AB operates an online auction platform in Sweden focused on vehicles, machinery, construction equipment, and industrial goods. The company combines an auction broker service with a self-service model, allowing both private individuals and businesses to buy and sell used objects. Its platform serves customers across Sweden who are active in sectors such as construction, transportation, agriculture, and manufacturing, as well as private sellers disposing of equipment. Vaxxa positions itself around enabling a more circular market by facilitating the resale and reuse of machinery and vehicles. Revenue is generated through auction commissions and related fees charged on transactions completed via the platform. The company operates primarily in the Swedish market and competes in the online marketplace and auction segment for heavy equipment and industrial assets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 77.49 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.96 | |||||
Beneish M-Score | -4.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 69.4 | |||||
3-Year EPS without NRI Growth Rate | 66.3 | |||||
3-Year Book Growth Rate | -43.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.3 | |||||
9-Day RSI | 48.23 | |||||
14-Day RSI | 47.46 | |||||
3-1 Month Momentum % | -7.83 | |||||
6-1 Month Momentum % | -22.91 | |||||
12-1 Month Momentum % | -31.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.98 | |||||
Days Inventory | 0.59 | |||||
Days Sales Outstanding | 6.9 | |||||
Days Payable | 1.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -80.4 | |||||
Shareholder Yield % | 0.39 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.68 | |||||
Operating Margin % | -3.83 | |||||
Net Margin % | -3.89 | |||||
EBITDA Margin % | -1.38 | |||||
FCF Margin % | 1.33 | |||||
OCF Margin % | 1.99 | |||||
ROE % | -20.84 | |||||
ROA % | -14.55 | |||||
ROIC % | -18.02 | |||||
3-Year ROIIC % | -523.29 | |||||
ROC (Joel Greenblatt) % | -908.41 | |||||
ROCE % | -20.3 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.19 | |||||
PB Ratio | 1.31 | |||||
Price-to-Tangible-Book | 8 | |||||
EV-to-EBIT | -1.47 | |||||
EV-to-EBITDA | -4.05 | |||||
EV-to-Revenue | 0.05 | |||||
EV-to-Forward-Revenue | 2.89 | |||||
EV-to-FCF | -2.11 | |||||
Price-to-GF-Value | 0.54 | |||||
Price-to-Projected-FCF | 2.11 | |||||
| Price-to-Net-Current-Asset-Value | 10 | |||||
Earnings Yield (Greenblatt) % | -68.53 | |||||
FCF Yield % | -13.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxxa AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 91.407 | ||
| EPS (TTM) (kr) | -0.082 | ||
| Beta | 0.0478 | ||
| 3-Year Sharpe Ratio | -0.36 | ||
| 3-Year Sortino Ratio | -0.56 | ||
| Volatility % | 43.69 | ||
| 14-Day RSI | 47.46 | ||
| 14-Day ATR (kr) | 0.03075 | ||
| 20-Day SMA (kr) | 0.40655 | ||
| 12-1 Month Momentum % | -31.83 | ||
| 52-Week Range (kr) | 0.351 - 0.904 | ||
| Shares Outstanding (Mil) | 43.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxxa AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxxa AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-24 | In 155 days | ||
| Third quarter earnings results for 2026 | 2026-10-20 | In 28 days | ||
| Second quarter earnings results for 2026 | 2026-07-16 | 0.47 (+0.21%) | ||
| General meeting for 2025 | 2026-04-23 | 0.66 (-9.32%) | ||
| First quarter earnings results for 2026 | 2026-04-22 | 0.75 (+10.29%) | ||
| Annual report for 2025 | 2026-04-02 | 0.54 (-0.37%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-24 | 0.80 (+18.34%) | ||
| Third quarter earnings results for 2025 | 2025-10-23 | 0.61 (+6.29%) | ||
| Second quarter earnings results for 2025 | 2025-07-17 | 1.01 (+8.84%) | ||
| General meeting for 2024 | 2025-04-24 09:00 | 0.75 (+6.21%) |
Show
Entries
Vaxxa AB Frequently Asked Questions
What is Vaxxa AB(XSAT:VAXXA)'s stock price today?
The current price of XSAT:VAXXA is kr0.41. The 52 week high of XSAT:VAXXA is kr0.90 and 52 week low is kr0.35.
When is next earnings date of Vaxxa AB(XSAT:VAXXA)?
The next earnings date of Vaxxa AB(XSAT:VAXXA) is 2026-10-20.
Does Vaxxa AB(XSAT:VAXXA) pay dividends? If so, how much?
Vaxxa AB(XSAT:VAXXA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers